Tag Archive for: Scancell

Optimum’s top take-aways from Anglonordic 2025

/in

If a good rule of thumb for a conference is how full the hall is at the end of the day compared to the start, then the 21st Anglonordic Life Science Conference held last Thursday, attended by well over 300 people, was a resounding success.  Maybe it was still full because attendees were keen to […]

Read more

ISA Pharmaceuticals announces the start of clinical trial using its novel AMPLIVANT® technology

/in

AMPLIVANT® adjuvant technology has the potential to increase vaccine immune response 10 – 100 fold Modi-1 clinical trial to begin in patients with triple negative breast cancer, ovarian cancer, head and neck cancer, and renal cancer Oegstgeest, The Netherlands, 14 April 2022 – ISA Pharmaceuticals today announces that a clinical trial using ISA’s novel AMPLIVANT® adjuvant […]

Read more